. 2018 Oct 24;7(12):1343–1353. doi: 10.1530/EC-18-0336
This work is licensed under a Table 1.
Baseline characteristics presented for all the 287 T1D patients and comparisons between the 162 men and the 125 women.
| All | Men | Women | P valuea | |
|---|---|---|---|---|
| n | 287 | 162 (56) | 125 (44) | – |
| Age (years) | 42 (31, 51; 18–59) | 43 (32, 52) | 41 (30, 50) | 0.11b |
| Diabetes duration (years) | 20 (11, 30; 1–55) | 20 (11, 32) | 19 (10, 29) | 0.23b |
| Hypoglycemia (severe episodes) | 12 (4) | 7 (4) | 5 (4) | >0.99 |
| Smokingc | 28 (10) | 18 (12) | 10 (8) | 0.43 |
| Physical inactivityd | 31 (12) | 18 (12) | 13 (11) | >0.99 |
| Antidepressants | 22 (8) | 11 (7) | 11 (9) | 0.66 |
| Oral anti diabetic drugs | 16 (6) | 6 (4) | 10 (8) | 0.13 |
| Lipid lowering drugs | 132 (46) | 78 (48) | 54 (43) | 0.47 |
| Antihypertensive drugs | 96 (33) | 61 (38) | 35 (28) | 0.10 |
| Cardiovascular complications | 10 (4) | 6 (4) | 4 (3) | >0.99 |
| Diabetic retinopathye | 206 (72) | 118 (73) | 88 (71) | 0.69 |
| Foot complicationsf | 47 (17) | 34 (22) | 13 (11) | 0.023 |
Data are presented as N (%), median (q1, q3; min–max), or median (q1, q3). aFisher’s Exact Test unless otherwise indicated; bMann–Whitney U test. Missing values: N = c16; d17; e2; f12.